Skip to main content
CanSino Biologics Inc. (SHA:688185)
China flag China · Delayed Price · Currency is CNY
60.47
-1.61 (-2.59%)
Jun 13, 2025, 2:45 PM CST

CanSino Biologics Revenue

CanSino Biologics had revenue of 137.16M CNY in the quarter ending March 31, 2025, with 20.02% growth. This brings the company's revenue in the last twelve months to 869.22M, up 134.41% year-over-year. In the year 2024, CanSino Biologics had annual revenue of 846.34M with 137.01% growth.

Revenue (ttm)
869.22M
Revenue Growth
+134.41%
P/S Ratio
12.87
Revenue / Employee
786.62K
Employees
1,105
Market Cap
11.19B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024846.34M489.25M137.01%
Dec 31, 2023357.08M-677.51M-65.49%
Dec 31, 20221.03B-3.27B-75.94%
Dec 31, 20214.30B4.27B17,174.82%
Dec 31, 202024.89M22.61M990.05%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jiangsu Hengrui Medicine 29.19B
Shenzhen Mindray Bio-Medical Electronics 35.59B
WuXi AppTec 39.59B
Sichuan Biokin Pharmaceutical 5.82B
Zhangzhou Pientzehuang Pharmaceutical., 10.76B
Aier Eye Hospital Group 21.81B
Shanghai United Imaging Healthcare 10.43B
Yunnan Baiyao Group Co.,Ltd 40.10B
Revenue Rankings

CanSino Biologics News

More News